1.1.1 Welcome to the Medical Technology and Evaluation Course

1.1.2 About Your Instructor Eric Barrette!

1.2.1 Introduction to the medical technology clients

1.2.2 The unique need for medical technology assessment

1.2.3 How do new technologies impact health care expenditures?

1.3.1 The new technology regulatory environment

1.3.2 Pharmaceuticals Regulation

1.3.3 Medical Device Regulation

1.4.1 Government vs. Private Payers

1.4.2 Inpatient Hospital Payments

1.4.3 Prescription Drug Payments

Medical Technology Assessment Environment

Relevant Stakeholders and Incentives

New Medical Technologies Approval

New Medical Technologies Reimbursement

How do Competing Interests Shape the Development of New Technologies?

2.1.1 Introduction to Clinical Trial

2.1.2 The Role of Randomization

2.1.3 Blinded Designs

2.2.1 Introduction to Administrative Data

2.2.2 Elements of Claims Data

2.2.3 Sources of Claims Data

2.3.1 Bias in Data

2.3.2 Combining Trial Data

2.3.3 Using Claims Data

Clinical Trials and Insurance Claims Data

Clinical Trial Design

Administrative (claims) data

Using Data

What do you think about not approving a clinical trial because a drug is expected to be TOO effective?

3.1.1 The Types and Uses of Assessments

3.1.2 CEA vs CUA

3.1.3 Resources

3.2.1 Introductions to Costs

3.2.2 Costing

3.2.3 Considerations

3.3.1 Benefits

3.3.2 Quality Adjusted Life Years (QALYs)

3.3.3 Measuring Quality of Life (QoL)

Medical Technology Assessment Basics

Measuring Costs

Measuring Effectiveness

You Are The Consultant

Would you rather have a longer life in worse health or a shorter life in better health?

"4.1.1 Uses of CEA

" "4.1.2 Constructing an ICER

" "4.1.3 Interpreting an ICER

" "4.2.1 Baye’s Rule

" "4.2.2 Discounting

" "4.2.3 Decision Models

" "4.3.1 Introduction to Uncertainty

" "4.3.2 Monte Carlo Simulation

" "4.3.3 Markov Models

" Methodological Approaches and Considerations

Conducting a Cost Effectiveness Analysis

Advanced Methodologies